Livzon Pharmaceutical Group Inc. (SZSE:000513) announces a share repurchase program. Under the program, the company will repurchase up to CNY 600 million worth of its class A shares. The program will be valid for a period of 12 months.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.3 CNY | -0.79% | -0.44% | +15.11% |
14/05 | Livzon Pharmaceutical Group Cancels Share Options | MT |
14/05 | Livzon Pharmaceutical Declares Final Dividend for 2023 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.11% | 4.6B | |
+35.01% | 709B | |
+30.90% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.79% | 239B | |
+9.50% | 211B | |
-3.80% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Livzon Pharmaceutical Group Inc. announces an Equity Buyback for CNY 600 million worth of its shares.